Navigation Links
InspireMD Reports Results for Period Ended Dec. 31, 2012
Date:2/4/2013

name">Ofir Paz , who previously announced his intention to step down as CEO in Sept. 2012 once a successor was named. Mr. Paz continues to serve as a director.

Mr. Milinazzo, who previously served in executive positions at Medtronic and Boston Scientific Corporation, brings more than 15 years of important commercial, operations, and international experience in interventional cardiology to bear on InspireMD's commercial strategy and operations as it launches the MGuard EPS platform.

He was instrumental in the launch of ENDEAVOR, Medtronic's first drug eluting stent platform, which has since generated more than $1 billion in revenue. He previously spent 12 years in executive positions at Boston Scientific, another major stent producer, serving as Vice President of Marketing at its $200 million SCIMED European unit, responsible for product launches, clinical programs and regulatory strategies.

Mr. Milinazzo most recently served as President and CEO of Nasdaq-quoted Orthofix International N.V., positions he was promoted to in 2006 after being hired a year earlier as Chief Operating Officer.  During his tenure at Orthofix, Mr. Milinazzo transformed it into a category leader in novel spine and orthopedic stem cell therapy, while growing revenue from $300 million to $580 million and nearly doubling profits.

In commenting on Mr. Milinazzo's appointments, Sol J. Barer , PhD, Chairman of InspireMD said: "Alan brings an exceptional set of experiences to us as a proven executive in the medical device field, particularly as relates to interventional cardiology and stents specifically. He brings a long list of strategically and commercially important accomplishments as a public company executive, he has the right blend of domestic and international experience for a company with our opportunities and intentions, and a well-documented entrepreneurial drive that's critical to success in managing the evolving needs
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
2. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
3. InspireMD Reports Results For Period Ending Sept. 30, 2012
4. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
5. InspireMD to Present at Harvard Investors Group on June 27 in New York
6. InspireMD to Present at Inaugural Marcum Microcap Conference on June 20th in New York
7. InspireMD Announces Positive 3-Year Results from Extended MAGICAL trial
8. InspireMD Announces First Quarter 2012 Financial Results
9. BRICS NPWT Market and Pressure Relief Devices Industry Analysis in New Research Reports at ReportsnReports.com
10. Trimedyne Reports Financial Results For The Quarter And Fiscal Year Ended September 30, 2012
11. Perrigo Reports Record Second Quarter Revenue, Adjusted Earnings and Operating Cash Flow
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Calif. , Sept. 1, 2015 ... Care Management (CCM) and Drug Adherence m Health ... help automate the process of non face-to-face monitoring ... "With this new release of our apps, doctors ... management services along with our ONCHIT certified Physician, ...
(Date:9/1/2015)... September 1, 2015 The ... the basis of sectors, products & services and ... coupled with the increasing demand of advanced drugs ... to propel the growth for bioinformatics market. The ... efficiently is known as bioinformatics. Decreasing cost of ...
(Date:9/1/2015)... -- In nur zwei Jahren nach dem Erreichen ... Group schnell weltweit 3.000 Mitarbeiter erreicht. Diese Steigerung ... Markt der injizierbaren Medikamente und das ... SHL wieder. Foto - http://photos.prnewswire.com/prnh/20150820/259886 ... Design und Herstellung automatischer Injektoren und Pen-Injektoren und ...
Breaking Medicine Technology:SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... 11, 2011 As part of its re-branding initiative, ... website www.xeridiem.com .  Winner of MD+DI,s 2011 Medical ... Supplies Xeridiem has been recognized as an industry leader ... invasive medical devices. For over 25 years, Xeridiem has ...
... Inc. (OTC: HEWA), a leading VIPPS-accredited, retail, mail-order ... have among the lowest total prices for four ... The study was conducted by 43,739 Consumer ... and speed.  "Our national study of prices for ...
Cached Medicine Technology:Consumer Reports Finds HealthWarehouse.com Has Lowest Total Price for Lipitor, Nexium, Plavix, and Singulair 2
(Date:9/1/2015)... ... ... The Journal of Pain Research has published the original research ... corresponding author Mr Christopher Malone says “Migraine headache is a painful chronic condition affecting ... understand how migraine headaches impact the lives of migraineurs. We asked migraineurs about a ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma community ... today announced its annual Light it Red for Lymphoma awareness initiative, the nation’s ...
(Date:9/1/2015)... , ... September 01, 2015 , ... Philanthropic giving in ... of societal issues and needs. Money for Good 2015, released today by Camber Collective, ... There’s an annual potential to mobilize up to $22B in new philanthropic giving and ...
(Date:9/1/2015)... ... September 01, 2015 , ... Consumers overwhelmingly ... Society for Dermatologic Surgery, according to a new survey that also offers insight ... Cosmetic Dermatologic Procedures – which reflects views on cosmetic medical treatments and ratings ...
(Date:9/1/2015)... ... September 01, 2015 , ... Virginia entrepreneur Marcella Ellis, ... strongly maintaining her firm’s success in the hair care and distribution industry through ... tour, Ellis will be providing “Look and learn” live demonstrations, as well as ...
Breaking Medicine News(10 mins):Health News:Migraine, treatment, comorbidities, and quality of life published by Dove Medical Press 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Beauty Entrepreneur creates hair extension smart machine and mobile app inspired by UBER technology 2
... 20, 2011) When two adjacent discs in the low ... or other symptoms, replacement with artificial discs can be a ... data from a randomized, multicenter trial recently published in the ... studies have compared single-disc replacement with fusion but this is ...
... All children should be screened for high cholesterol when they,re ... the National Lipid Association. The group also urges that ... elevated cholesterol be screened for cholesterol with a simple blood ... people know if a history of high cholesterol runs in ...
... (HealthDay News) -- People who have psoriasis and hypertension are ... more medications to control it, a new study suggests. ... causes itchy, thickened, dry, red patches on the skin. ... 835 patients who had psoriasis and hypertension. Their cases were ...
... as follows: SESSION I / Monday, May 23 ... Rates of Acute Coronary Syndrome Patients in Real World Clinical ... Gandhi SK2, Bhandary D2, Stephenson JJ1, Gold A2, Fu AC1, ... Wilmington, Del. SESSION II / Tuesday, May 24 ...
... Aage Moller of UT Dallas is known throughout the world ... But back at The University of Texas at Dallas, he,s ... Moller received the President,s Teaching Excellence Award for Tenure-Track ... was selected from among more than 100 eligible faculty members ...
... provides evidence for significant differences between new and old ... a cheap, rapid and effective way to monitor the ... preservatives, blood stored in banks continues to age, resulting ... subsequent changes to cell properties and function. There ...
Cached Medicine News:Health News:2-year results: Artificial disc a viable alternative to fusion for 2-level disc disease 2Health News:Experts Say Cholesterol Screenings Should Start in Childhood 2Health News:Psoriasis, High Blood Pressure May Be Linked 2Health News:HealthCore presents ISPOR poster sessions 2Health News:UT Dallas' Moller receives teaching award 2Health News:Research provides insight into quality of stored blood used for transfusions 2Health News:Research provides insight into quality of stored blood used for transfusions 3
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: